February 14th, 2007
New Discovery Can Predict Risk of “Graft-Versus-Host Disease” in Recipients of Graft of Donor T Cells
The best way to treat patients with blood cancers (certain leukemias and lymphomas) is by peripheral blood stem-cell grafts from immunologically-matched donors.
The setback however is the risk of one major complication: “graft-versus-host disease” (GVHD) - a rejection of recipient tissues by the donor’s T cells that see their new host as ‘non-self’.
60% of recipients develop […]
Recent Comments